JP3523252B2
(ja)
*
|
1990-11-21 |
2004-04-26 |
ホウテン ファーマシューティカルズ インコーポレイテッド |
等モル多種オリゴマー混合物、特にオリゴペプチド混合物の合成
|
US6197529B1
(en)
|
1990-11-21 |
2001-03-06 |
Torrey Pines Institute For Molecular Studies |
Linear substituted oligoalkyleneimine libraries
|
ZA924244B
(en)
*
|
1991-06-18 |
1993-12-10 |
Lilly Co Eli |
Rapid synthesis and screening of peptide mimetics
|
JPH07501929A
(ja)
*
|
1991-08-23 |
1995-03-02 |
アイシス・ファーマシューティカルス・インコーポレーテッド |
オリゴマーフラグメントの合成非ランダム化
|
US5747253A
(en)
*
|
1991-08-23 |
1998-05-05 |
Isis Pharmaceuticals, Inc. |
Combinatorial oligomer immunoabsorbant screening assay for transcription factors and other biomolecule binding
|
EP0604552B1
(en)
*
|
1991-09-18 |
1997-02-12 |
Affymax Technologies N.V. |
Method of synthesizing diverse collections of oligomers
|
US5885965A
(en)
*
|
1991-11-01 |
1999-03-23 |
Periodontix, Inc. |
Anti-fungal D-amino acid histatin-based peptides
|
US5646119A
(en)
*
|
1991-11-01 |
1997-07-08 |
Periodontix, Inc. |
D-amino acid histatin-based peptides as anti-fungal and anti-bacterial agents
|
US5573905A
(en)
*
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
US5541061A
(en)
*
|
1992-04-29 |
1996-07-30 |
Affymax Technologies N.V. |
Methods for screening factorial chemical libraries
|
US6548279B1
(en)
*
|
1992-06-05 |
2003-04-15 |
The Scripps Research Institute |
D-enzyme compositions and methods of their use
|
US5721099A
(en)
*
|
1992-10-01 |
1998-02-24 |
Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US6503759B1
(en)
|
1992-10-01 |
2003-01-07 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5565324A
(en)
*
|
1992-10-01 |
1996-10-15 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5807683A
(en)
*
|
1992-11-19 |
1998-09-15 |
Combichem, Inc. |
Combinatorial libraries and methods for their use
|
US5786327A
(en)
|
1993-03-12 |
1998-07-28 |
Gensci Regeneration Sciences Inc. |
Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same
|
AU6281594A
(en)
*
|
1993-03-12 |
1994-09-26 |
Jerini Bio Chemicals Gmbh |
Process for synthesizing and selecting sequences of covalently bound components
|
US6864048B2
(en)
*
|
1993-04-28 |
2005-03-08 |
Affymetrix, Inc. |
Factorial chemical libraries
|
US5846731A
(en)
*
|
1993-06-17 |
1998-12-08 |
Torry Pines Institute For Molecular Studies |
Peralkylated oligopeptide mixtures
|
US5480971A
(en)
*
|
1993-06-17 |
1996-01-02 |
Houghten Pharmaceuticals, Inc. |
Peralkylated oligopeptide mixtures
|
WO1995001800A1
(en)
|
1993-07-09 |
1995-01-19 |
Smithkline Beecham Corporation |
Cyclic semi-random peptide libraries
|
WO1995003315A2
(en)
*
|
1993-07-21 |
1995-02-02 |
Oxford Glycosystems Ltd |
Saccharides, their synthesis and use
|
CN1154640C
(zh)
*
|
1993-10-01 |
2004-06-23 |
纽约市哥伦比亚大学理事 |
用标示物编码的多元组合化学库
|
CA2175579A1
(en)
*
|
1993-10-26 |
1995-05-04 |
Chang Yi Wang |
Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics
|
US5503805A
(en)
*
|
1993-11-02 |
1996-04-02 |
Affymax Technologies N.V. |
Apparatus and method for parallel coupling reactions
|
US6287787B1
(en)
|
1993-11-24 |
2001-09-11 |
Torrey Pines Institute For Molecular Studies |
Dimeric oligopeptide mixture sets
|
US5965536A
(en)
*
|
1993-12-15 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods of inhibiting CXC intercrine molecules
|
AU685079B2
(en)
*
|
1993-12-15 |
1998-01-15 |
Board Of Regents, The University Of Texas System |
Peptide inhibitors of CXC intercrine molecules
|
WO1995016918A1
(en)
*
|
1993-12-15 |
1995-06-22 |
Combichem, Inc. |
Combinatorial libraries and methods for their use
|
US5587471A
(en)
*
|
1994-01-11 |
1996-12-24 |
Isis Pharmaceuticals, Inc. |
Method of making oligonucleotide libraries
|
WO1995019567A1
(en)
*
|
1994-01-13 |
1995-07-20 |
The Trustees Of Columbia University In The City Of New York |
Synthetic receptors, libraries and uses thereof
|
US6936477B2
(en)
|
1994-04-13 |
2005-08-30 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5738996A
(en)
*
|
1994-06-15 |
1998-04-14 |
Pence, Inc. |
Combinational library composition and method
|
US5824483A
(en)
*
|
1994-05-18 |
1998-10-20 |
Pence Inc. |
Conformationally-restricted combinatiorial library composition and method
|
US5939268A
(en)
*
|
1994-07-26 |
1999-08-17 |
The Scripps Research Institute |
Combinatorial libraries of molecules and methods for producing same
|
US5645996A
(en)
*
|
1994-08-24 |
1997-07-08 |
Torrey Pines Institute For Molecular Studies |
Melittin-related polypeptides, mixture sets and libraries thereof
|
US5582997A
(en)
*
|
1994-08-24 |
1996-12-10 |
Torrey Pines Institute For Molecular Studies |
Lysine/leucine polypeptides, mixture sets and libraries thereof
|
US5602097A
(en)
*
|
1994-09-13 |
1997-02-11 |
Ceres Technologies, Inc. |
Synthetic antibiotics
|
US6020312A
(en)
*
|
1994-09-13 |
2000-02-01 |
Nce Pharmaceuticals, Inc. |
Synthetic antibiotics
|
US5885782A
(en)
*
|
1994-09-13 |
1999-03-23 |
Nce Pharmaceuticals, Inc. |
Synthetic antibiotics
|
US20020169104A1
(en)
*
|
1997-05-01 |
2002-11-14 |
Glenn Frank |
Novel ectoparasite saliva proteins and apparatus to collect such proteins
|
US5741462A
(en)
|
1995-04-25 |
1998-04-21 |
Irori |
Remotely programmable matrices with memories
|
US6025129A
(en)
*
|
1995-04-25 |
2000-02-15 |
Irori |
Remotely programmable matrices with memories and uses thereof
|
US6017496A
(en)
|
1995-06-07 |
2000-01-25 |
Irori |
Matrices with memories and uses thereof
|
US5874214A
(en)
|
1995-04-25 |
1999-02-23 |
Irori |
Remotely programmable matrices with memories
|
US5751629A
(en)
|
1995-04-25 |
1998-05-12 |
Irori |
Remotely programmable matrices with memories
|
US6331273B1
(en)
|
1995-04-25 |
2001-12-18 |
Discovery Partners International |
Remotely programmable matrices with memories
|
US6329139B1
(en)
|
1995-04-25 |
2001-12-11 |
Discovery Partners International |
Automated sorting system for matrices with memory
|
US5925562A
(en)
*
|
1995-04-25 |
1999-07-20 |
Irori |
Remotely programmable matrices with memories
|
US6416714B1
(en)
|
1995-04-25 |
2002-07-09 |
Discovery Partners International, Inc. |
Remotely programmable matrices with memories
|
US6352973B1
(en)
*
|
1995-06-07 |
2002-03-05 |
Osteopharm Inc. |
Bone stimulating factor
|
US6693081B2
(en)
|
1995-09-26 |
2004-02-17 |
Osteopharm Inc. |
Bone stimulating factor
|
US5763263A
(en)
*
|
1995-11-27 |
1998-06-09 |
Dehlinger; Peter J. |
Method and apparatus for producing position addressable combinatorial libraries
|
US6277583B1
(en)
|
1996-02-07 |
2001-08-21 |
Conjuchem, Inc. |
Affinity labeling libraries and applications thereof
|
US6121489A
(en)
*
|
1996-03-05 |
2000-09-19 |
Trega Biosciences, Inc. |
Selectively N-alkylated peptidomimetic combinatorial libraries and compounds therein
|
WO1998013377A1
(en)
*
|
1996-03-06 |
1998-04-02 |
Biomolecular Research Institute Ltd. |
Cytotoxic peptides
|
US20020142352A1
(en)
*
|
1999-03-04 |
2002-10-03 |
Heska Corporation |
Novel ectoparasite salvia proteins and apparatus to collect such proteins
|
US6110889A
(en)
|
1996-06-14 |
2000-08-29 |
Board Of Regents, The University Of Texas System |
Peptide tumor cell growth inhibitors
|
US5804436A
(en)
*
|
1996-08-02 |
1998-09-08 |
Axiom Biotechnologies, Inc. |
Apparatus and method for real-time measurement of cellular response
|
US6558916B2
(en)
|
1996-08-02 |
2003-05-06 |
Axiom Biotechnologies, Inc. |
Cell flow apparatus and method for real-time measurements of patient cellular responses
|
US6280967B1
(en)
|
1996-08-02 |
2001-08-28 |
Axiom Biotechnologies, Inc. |
Cell flow apparatus and method for real-time of cellular responses
|
AUPO161196A0
(en)
*
|
1996-08-13 |
1996-09-05 |
Commonwealth Scientific And Industrial Research Organisation |
Novel compounds
|
CA2267769A1
(en)
*
|
1996-10-07 |
1998-04-16 |
Irori |
Matrices with memories in automated drug discovery and units therefor
|
DE19643314A1
(de)
*
|
1996-10-21 |
1998-04-23 |
Boehringer Mannheim Gmbh |
Monoklonale Antikörper gegen das Epitop YPYDVPDYA, Verfahren zu deren Herstellung und Verwendung
|
US6617114B1
(en)
|
1996-10-31 |
2003-09-09 |
Karo Bio Ab |
Identification of drug complementary combinatorial libraries
|
US6441172B1
(en)
*
|
1996-11-07 |
2002-08-27 |
Torrey Pines Institute For Molecular Studies |
Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
|
US5859191A
(en)
*
|
1996-12-05 |
1999-01-12 |
The Regents Of The University Of California |
Method for the site-specific modification of peptide alpha amines
|
JP4663824B2
(ja)
*
|
1996-12-31 |
2011-04-06 |
ハイ スループット ジェノミクス インコーポレイテッド |
多重化分子分析装置および方法
|
US6262269B1
(en)
|
1997-02-04 |
2001-07-17 |
Trega Biosciences, Inc. |
4-Substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries
|
US6004823A
(en)
*
|
1997-05-07 |
1999-12-21 |
Smithkline Beecham Corporation |
Compounds
|
US5908960A
(en)
*
|
1997-05-07 |
1999-06-01 |
Smithkline Beecham Corporation |
Compounds
|
CA2289719A1
(en)
*
|
1997-05-08 |
1998-11-12 |
Ravi S. Garigipati |
Chloride linker for solid phase organic synthesis
|
ATE218892T1
(de)
|
1997-11-07 |
2002-06-15 |
Conjuchem Inc |
Affinitätsmarkierer für menschliches serum albumin
|
US6190920B1
(en)
|
1997-11-12 |
2001-02-20 |
The Regents Of The University Of California |
Method for detecting enzyme catalyzed cyclization
|
US20030039967A1
(en)
*
|
1997-12-19 |
2003-02-27 |
Kris Richard M. |
High throughput assay system using mass spectrometry
|
US20100105572A1
(en)
*
|
1997-12-19 |
2010-04-29 |
Kris Richard M |
High throughput assay system
|
US20030096232A1
(en)
*
|
1997-12-19 |
2003-05-22 |
Kris Richard M. |
High throughput assay system
|
GB9808783D0
(en)
*
|
1998-04-25 |
1998-06-24 |
Central Research Lab Ltd |
Labelling of small articles
|
US6541211B1
(en)
*
|
1998-05-20 |
2003-04-01 |
Selectide Corporation |
Apparatus and method for synthesizing combinational libraries
|
US6872535B2
(en)
*
|
1998-05-20 |
2005-03-29 |
Aventis Pharmaceuticals Inc. |
Three-dimensional array of supports for solid-phase parallel synthesis and method of use
|
EP2360271A1
(en)
|
1998-06-24 |
2011-08-24 |
Illumina, Inc. |
Decoding of array sensors with microspheres
|
NZ511629A
(en)
*
|
1998-11-13 |
2004-04-30 |
Pepscan Systems B |
A method for determining a mimotope sequence
|
US6846460B1
(en)
|
1999-01-29 |
2005-01-25 |
Illumina, Inc. |
Apparatus and method for separation of liquid phases of different density and for fluorous phase organic syntheses
|
EP1147229A2
(en)
|
1999-02-02 |
2001-10-24 |
Bernhard O. Palsson |
Methods for identifying drug targets based on genomic sequence data
|
US6500609B1
(en)
|
1999-02-11 |
2002-12-31 |
Scynexis Chemistry & Automation, Inc. |
Method and apparatus for synthesizing characterizing and assaying combinatorial libraries
|
US6362342B1
(en)
|
1999-06-29 |
2002-03-26 |
Lion Bioscience Ag |
Triazole compounds and methods of making same
|
US6524863B1
(en)
|
1999-08-04 |
2003-02-25 |
Scynexis Chemistry & Automation, Inc. |
High throughput HPLC method for determining Log P values
|
US6413431B1
(en)
|
1999-08-10 |
2002-07-02 |
Scynexis Chemistry & Automation, Inc. |
HPLC method for purifying organic compounds
|
EP1218545B1
(en)
|
1999-08-18 |
2012-01-25 |
Illumina, Inc. |
Methods for preparing oligonucleotide solutions
|
US6387273B1
(en)
|
1999-08-27 |
2002-05-14 |
Scynexis Chemistry & Automation, Inc. |
Sample preparation for high throughput purification
|
US9289487B2
(en)
*
|
1999-09-14 |
2016-03-22 |
Antigen Express, Inc. |
II-key/antigenic epitope hybrid peptide vaccines
|
US20030235594A1
(en)
*
|
1999-09-14 |
2003-12-25 |
Antigen Express, Inc. |
Ii-Key/antigenic epitope hybrid peptide vaccines
|
US6432409B1
(en)
*
|
1999-09-14 |
2002-08-13 |
Antigen Express, Inc. |
Hybrid peptides modulate the immune response
|
US6545032B1
(en)
|
1999-09-17 |
2003-04-08 |
Torrey Pines Institute For Molecular Studies |
Synthesis of [3,5,7]-H-imidazo[1,5-a] imidazol-2(3H)-one compounds
|
US6632616B2
(en)
|
2000-03-16 |
2003-10-14 |
Duke University |
Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof
|
CA2412011A1
(en)
*
|
2000-06-16 |
2001-12-27 |
Hercules Incorporated |
Chemically-modified antimicrobial peptides, compositions and methods of production and use
|
IL153359A0
(en)
*
|
2000-06-16 |
2003-07-06 |
Hercules Inc |
Peptides, compositions and methods for the treatment of burkholderia cepacia
|
EP1328658A2
(en)
*
|
2000-06-22 |
2003-07-23 |
San Diego State University Foundation |
Recombination modulators and methods for their production and use
|
US6759510B1
(en)
*
|
2000-06-30 |
2004-07-06 |
Becton, Dickinson And Company |
Peptides for use in culture media
|
AU2001296846B2
(en)
|
2000-10-12 |
2007-07-05 |
University Of Rochester |
Compositions that inhibit proliferation of cancer cells
|
US20040229382A1
(en)
*
|
2000-10-23 |
2004-11-18 |
Ronald Breaker |
Characterized arrangements of mixtures (CAM) using polymers
|
DE10059890A1
(de)
*
|
2000-12-01 |
2002-06-20 |
Hte Ag |
Verfahren zur Herstellung einer Vielzahl von Bausteinen einer Materialbibliothek
|
AUPR279101A0
(en)
*
|
2001-01-30 |
2001-02-22 |
Cytopia Pty Ltd |
Protein kinase signalling
|
US7127379B2
(en)
*
|
2001-01-31 |
2006-10-24 |
The Regents Of The University Of California |
Method for the evolutionary design of biochemical reaction networks
|
US20030059792A1
(en)
*
|
2001-03-01 |
2003-03-27 |
Palsson Bernhard O. |
Models and methods for determining systemic properties of regulated reaction networks
|
US7265208B2
(en)
|
2001-05-01 |
2007-09-04 |
The Regents Of The University Of California |
Fusion molecules and treatment of IgE-mediated allergic diseases
|
WO2002088317A2
(en)
|
2001-05-01 |
2002-11-07 |
The Regents Of The University Of California |
Fusion molecules and methods for treatment of immune diseases
|
US7138506B2
(en)
|
2001-05-09 |
2006-11-21 |
Genetic Id, Na, Inc. |
Universal microarray system
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
US6955888B2
(en)
|
2001-06-11 |
2005-10-18 |
Xenoport |
Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
|
EP2000148A1
(en)
|
2001-06-20 |
2008-12-10 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of prostate cancer
|
US7803915B2
(en)
|
2001-06-20 |
2010-09-28 |
Genentech, Inc. |
Antibody compositions for the diagnosis and treatment of tumor
|
JP4351043B2
(ja)
|
2001-07-09 |
2009-10-28 |
エラン ファーマシューティカルズ,インコーポレイテッド |
アミロイド毒性の阻害方法
|
CN1215081C
(zh)
*
|
2001-07-13 |
2005-08-17 |
深圳市康哲药业股份有限公司 |
序列号16的生物活性肽
|
NZ531674A
(en)
|
2001-09-18 |
2009-03-31 |
Genentech Inc |
Compositions and methods for the diagnosis and treatment of tumor
|
US7751981B2
(en)
|
2001-10-26 |
2010-07-06 |
The Regents Of The University Of California |
Articles of manufacture and methods for modeling Saccharomyces cerevisiae metabolism
|
US20060258581A1
(en)
*
|
2001-11-21 |
2006-11-16 |
Reed John C |
Methods and composition for derepressions of IAP-inhibited caspase
|
US20050119176A1
(en)
*
|
2001-11-21 |
2005-06-02 |
The Burnham Institute |
Methods and compositions for derepression of IAP-inhibited caspase
|
CA2467892A1
(en)
*
|
2001-11-21 |
2003-06-05 |
The Burnham Institute |
Methods and compositions for derepression of iap-inhibited caspase
|
EP2067472A1
(en)
|
2002-01-02 |
2009-06-10 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US7811992B2
(en)
|
2002-02-06 |
2010-10-12 |
Stasys Technologies, Inc. |
Anti-infarction molecules
|
US6861523B2
(en)
|
2002-02-08 |
2005-03-01 |
Torrey Pines Institute For Molecular Studies |
1,3,5- trisubstituted-1,3,5-triazine-2,4,6-trione compounds and libraries
|
US20030224363A1
(en)
*
|
2002-03-19 |
2003-12-04 |
Park Sung M. |
Compositions and methods for modeling bacillus subtilis metabolism
|
AU2003222128A1
(en)
|
2002-03-29 |
2003-10-13 |
Genomatica, Inc. |
Human metabolic models and methods
|
US8949032B2
(en)
|
2002-03-29 |
2015-02-03 |
Genomatica, Inc. |
Multicellular metabolic models and methods
|
NZ535925A
(en)
|
2002-04-16 |
2008-06-30 |
Genentech Inc |
An isolated antibody that binds to a particular polypeptide
|
EP1501935B1
(en)
*
|
2002-04-22 |
2009-09-23 |
Dow Global Technologies Inc. |
Low-cost production of peptides
|
EP2305710A3
(en)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
US7856317B2
(en)
|
2002-06-14 |
2010-12-21 |
Genomatica, Inc. |
Systems and methods for constructing genomic-based phenotypic models
|
CA2495478A1
(en)
|
2002-08-05 |
2004-02-12 |
University Of Rochester |
Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
|
CA2496925A1
(en)
*
|
2002-08-29 |
2004-03-11 |
Genentech, Inc. |
Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor
|
EP1556072B1
(en)
|
2002-09-17 |
2010-05-19 |
Antigen Express, Inc. |
Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES
|
US7179645B2
(en)
*
|
2002-09-24 |
2007-02-20 |
Antigen Express, Inc. |
Ii-Key/antigenic epitope hybrid peptide vaccines
|
WO2004035009A2
(en)
|
2002-10-15 |
2004-04-29 |
The Regents Of The University Of California |
Methods and systems to identify operational reaction pathways
|
US7869957B2
(en)
|
2002-10-15 |
2011-01-11 |
The Regents Of The University Of California |
Methods and systems to identify operational reaction pathways
|
AU2003295824A1
(en)
*
|
2002-11-22 |
2004-06-18 |
Incyte Corporation |
Cell adhesion and extracellular matrix proteins
|
AU2003291871A1
(en)
*
|
2002-12-05 |
2004-06-23 |
Osteopharm Inc. |
Bone growth factor
|
AU2004225923A1
(en)
*
|
2003-03-28 |
2004-10-14 |
The Rockefeller University |
Peptides for reducing symptoms of toxic shock syndrome and septic shck
|
CA2530284A1
(en)
|
2003-07-08 |
2005-02-03 |
Genentech, Inc. |
Il-17 a/f heterologous polypeptides and therapeutic uses thereof
|
ES2472690T3
(es)
|
2003-11-17 |
2014-07-02 |
Genentech, Inc. |
Anticuerpo contra CD22 para el tratamiento de tumores de origen hematopoy�tico
|
US20050136538A1
(en)
*
|
2003-12-17 |
2005-06-23 |
Srikant Pathak |
Lithographic method for attaching biological cells to a solid substrate using a small molecule linker
|
KR101228356B1
(ko)
|
2004-04-08 |
2013-02-05 |
바이오매트리카 인코포레이티드 |
생명과학용 시료 보관 및 시료 관리의 통합
|
US20050261474A1
(en)
*
|
2004-05-20 |
2005-11-24 |
Mixture Sciences, Inc. |
Method of support-based chemical synthesis
|
EP1600455A1
(en)
*
|
2004-05-28 |
2005-11-30 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Preparation of solid phase bound peptides or PNAs
|
US7488804B2
(en)
|
2005-02-02 |
2009-02-10 |
The Regents Of The University Of California |
Modified fusion molecules for treatment of allergic disease
|
CN101175769A
(zh)
|
2005-03-10 |
2008-05-07 |
健泰科生物技术公司 |
用于调控血管完整性的方法和组合物
|
US20070003535A1
(en)
*
|
2005-03-17 |
2007-01-04 |
Reed John C |
Methods and compositions for derepression of IAP-inhibited caspase
|
EP1874950B1
(en)
|
2005-04-05 |
2015-06-03 |
Corning Incorporated |
Label free biosensors
|
AU2005332058B2
(en)
|
2005-05-19 |
2011-12-01 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention |
Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereof
|
CA2610709A1
(en)
|
2005-06-06 |
2006-12-14 |
Genentech, Inc. |
Transgenic models for different genes and their use for gene characterization
|
EP1995321A2
(en)
|
2005-08-15 |
2008-11-26 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
AU2006304321B2
(en)
|
2005-10-14 |
2012-10-04 |
Musc Foundation For Research Development |
Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
|
US8080534B2
(en)
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
US7576037B2
(en)
|
2005-11-18 |
2009-08-18 |
Mei Technologies, Inc. |
Process and apparatus for combinatorial synthesis
|
EP1962584A2
(en)
|
2005-11-21 |
2008-09-03 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
KR101453570B1
(ko)
|
2005-12-02 |
2014-10-22 |
제넨테크, 인크. |
Il-22 및 il-22r에 결합하는 항체를 포함하는,사이토카인 신호 전달과 관련된 질환 및 장애 치료용조성물 및 치료 방법
|
WO2007114979A2
(en)
|
2006-02-17 |
2007-10-11 |
Genentech, Inc. |
Gene disruptons, compositions and methods relating thereto
|
EP2007428A2
(en)
|
2006-04-05 |
2008-12-31 |
Genentech, Inc. |
Method for using boc/cdo to modulate hedgehog signaling
|
WO2008036437A2
(en)
|
2006-04-19 |
2008-03-27 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
US20090142259A1
(en)
*
|
2006-05-12 |
2009-06-04 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors
|
EP2520935A3
(en)
|
2006-08-09 |
2013-02-13 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
CA2662236A1
(en)
|
2006-09-12 |
2008-03-20 |
Genentech, Inc. |
Methods and compositions for the diagnosis and treatment of cancer
|
CA2664189C
(en)
|
2006-09-21 |
2017-11-21 |
University Of Rochester |
Compositions and methods related to protein displacement therapy for myotonic dystrophy
|
US7834140B2
(en)
*
|
2006-10-12 |
2010-11-16 |
Saint Louis University |
Polypeptide fragment of constitutive coactivator of PPARgamma
|
WO2008136852A2
(en)
|
2006-11-01 |
2008-11-13 |
University Of Rochester |
Methods and compositions related to the structure and function of apobec3g
|
WO2008067196A2
(en)
|
2006-11-16 |
2008-06-05 |
The Regents Of The University Of California |
Methods for identifying inhibitors of solute transporters
|
WO2008085794A2
(en)
|
2007-01-03 |
2008-07-17 |
Burnham Institute For Medical Research |
Methods and compositions related to clot binding compounds
|
CA2677665C
(en)
|
2007-02-08 |
2019-11-05 |
University Of Utah Research Foundation |
Methods and compositions related to inhibition of viral entry
|
KR101508397B1
(ko)
|
2007-02-22 |
2015-04-08 |
제넨테크, 인크. |
염증성 장 질환의 검출 방법
|
WO2009012143A2
(en)
*
|
2007-07-13 |
2009-01-22 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Virus derived antimicrobial peptides
|
US20090023182A1
(en)
*
|
2007-07-18 |
2009-01-22 |
Schilling Christophe H |
Complementary metabolizing organisms and methods of making same
|
US20100204111A1
(en)
*
|
2007-09-11 |
2010-08-12 |
Dorian Bevec |
Astressin and beta- endorphin for use as therapeutic agents
|
WO2009033787A2
(en)
*
|
2007-09-11 |
2009-03-19 |
Mondobiotech Laboratories Ag |
Use of a peptide as a therapeutic agent
|
WO2009033732A2
(en)
*
|
2007-09-11 |
2009-03-19 |
Mondobiotech Laboratories Ag |
Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agent
|
AU2008307145B2
(en)
*
|
2007-10-04 |
2014-07-10 |
Bionomics Limited |
Markers of endothelial cells and uses thereof
|
PT2514436T
(pt)
|
2007-11-07 |
2018-03-21 |
Genentech Inc |
Il-22 para utilização no tratamento de distúrbios microbianos
|
WO2009079373A2
(en)
|
2007-12-14 |
2009-06-25 |
The Regents Of The University Of California |
Inhibitors of calcium-activated chloride channels
|
WO2009105591A2
(en)
|
2008-02-19 |
2009-08-27 |
The Regents Of The University Of California |
Methods and systems for genome-scale kinetic modeling
|
US7928189B2
(en)
*
|
2008-05-05 |
2011-04-19 |
Ottawa Health Research Institute |
PCSK9 polypeptide fragment
|
US9182406B2
(en)
|
2008-08-04 |
2015-11-10 |
Biodesy, Inc. |
Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability
|
US8816095B2
(en)
*
|
2008-08-15 |
2014-08-26 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
EP2370080A1
(en)
|
2008-12-02 |
2011-10-05 |
University of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
CN104479018B
(zh)
|
2008-12-09 |
2018-09-21 |
霍夫曼-拉罗奇有限公司 |
抗-pd-l1抗体及它们用于增强t细胞功能的用途
|
EP2391748A4
(en)
*
|
2009-01-28 |
2012-08-01 |
Antigen Express Inc |
LI-KEY HYBRID PEPTIDES MODULATING IMMUNE RESPONSE TO FLU
|
WO2010102140A1
(en)
|
2009-03-04 |
2010-09-10 |
The Trustees Of The University Of Pennsylvania |
Compositions comprising angiogenic factors and methods of use thereof
|
US20120149663A1
(en)
|
2009-08-18 |
2012-06-14 |
Georgetown University |
Boronic acid compositions and methods related to cancer
|
JP5885664B2
(ja)
|
2009-09-25 |
2016-03-15 |
ゾーマ テクノロジー リミテッド |
スクリーニング法
|
US8926976B2
(en)
*
|
2009-09-25 |
2015-01-06 |
Xoma Technology Ltd. |
Modulators
|
EP2485768A1
(en)
|
2009-10-07 |
2012-08-15 |
Sanford-Burnham Medical Research Institute |
Methods and compositions related to clot-binding lipid compounds
|
KR20120105446A
(ko)
|
2009-10-22 |
2012-09-25 |
제넨테크, 인크. |
대식세포-자극 단백질의 헵신 활성화를 조정하기 위한 방법 및 조성물
|
RU2015132142A
(ru)
|
2009-11-30 |
2015-12-20 |
Дженентек, Инк. |
Композиции и способы для диагностики и лечения опухоли
|
JP2013515008A
(ja)
|
2009-12-18 |
2013-05-02 |
サンフォード−バーナム メディカル リサーチ インスティテュート |
凝血塊結合化合物に関連する方法および組成物
|
SG183333A1
(en)
|
2010-02-18 |
2012-09-27 |
Genentech Inc |
Neuregulin antagonists and use thereof in treating cancer
|
CA2787657A1
(en)
|
2010-02-23 |
2011-09-01 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
EP2547690B1
(en)
*
|
2010-03-16 |
2016-08-17 |
Advanced Technologies and Regenerative Medicine, LLC |
Affinity peptides toward bmp-2
|
CA2793544A1
(en)
|
2010-05-03 |
2011-11-10 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
EP2598661B1
(en)
|
2010-07-26 |
2017-09-27 |
Biomatrica, INC. |
Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
|
CA2806670A1
(en)
|
2010-07-26 |
2012-02-09 |
Biomatrica, Inc. |
Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
|
WO2012071436A1
(en)
|
2010-11-24 |
2012-05-31 |
Genentech, Inc. |
Method of treating autoimmune inflammatory disorders using il-23r loss-of-function mutants
|
US8112218B2
(en)
*
|
2011-03-10 |
2012-02-07 |
Ford Global Technologies, Llc |
Method for controlling an engine
|
AU2012230899A1
(en)
|
2011-03-21 |
2013-10-10 |
Biodesy, Llc |
Classification of kinase inhibitors using nonlinear optical techniques
|
CA2868735C
(en)
|
2011-03-28 |
2020-02-25 |
University Of Utah Research Foundation |
D-peptide conjugates comprising a membrane localizing potency-enhancing cargo molecule for inhibiting hiv entry
|
US10352936B2
(en)
|
2011-04-14 |
2019-07-16 |
Apoplogic Pharmaceuticals, Inc. |
Use of tumor Fas expression to determine response to anti-cancer therapy
|
UA117220C2
(uk)
|
2011-08-01 |
2018-07-10 |
Дженентек, Інк. |
Способи лікування раку з використанням антагоністів, що зв'язуються з віссю pd-1, і інгібіторів mek
|
WO2013040433A1
(en)
|
2011-09-15 |
2013-03-21 |
Genentech, Inc. |
Methods of promoting differentiation
|
MX2014004426A
(es)
|
2011-10-15 |
2014-07-09 |
Genentech Inc |
Metodos de uso de antagonistas de scd1.
|
CA2851828A1
(en)
|
2011-10-28 |
2013-05-02 |
Presage Biosciences, Inc. |
Methods for drug delivery
|
EP2804630B1
(en)
|
2012-01-18 |
2017-10-18 |
F. Hoffmann-La Roche AG |
Methods of using fgf19 modulators
|
EP2812350B1
(en)
|
2012-02-11 |
2019-04-03 |
F.Hoffmann-La Roche Ag |
R-spondin translocations and methods using the same
|
WO2013135745A1
(en)
|
2012-03-16 |
2013-09-19 |
F. Hoffmann-La Roche Ag |
Methods of treating melanoma with pak1 inhibitors
|
US9139863B2
(en)
|
2012-03-16 |
2015-09-22 |
Genentech, Inc. |
Engineered conformationally-stabilized proteins
|
EP2825549B1
(en)
|
2012-03-16 |
2018-10-10 |
F. Hoffmann-La Roche SA |
Engineered conformationally-stabilized proteins
|
CN106290917B
(zh)
|
2012-04-25 |
2020-06-05 |
比奥德赛公司 |
用于检测蛋白质的变构调节剂的方法
|
WO2013170191A1
(en)
|
2012-05-11 |
2013-11-14 |
Genentech, Inc. |
Methods of using antagonists of nad biosynthesis from nicotinamide
|
CA2874144C
(en)
|
2012-05-31 |
2023-12-19 |
Genentech, Inc. |
Methods of treating cancer using pd-l1 axis binding antagonists and vegf antagonists
|
EP2934572A4
(en)
|
2012-12-20 |
2016-11-23 |
Biomatrica Inc |
FORMULATIONS AND METHODS FOR STABILIZING PCR REAGENTS
|
CN104994879A
(zh)
|
2013-02-22 |
2015-10-21 |
霍夫曼-拉罗奇有限公司 |
治疗癌症和预防药物抗性的方法
|
RU2015139054A
(ru)
|
2013-03-14 |
2017-04-19 |
Дженентек, Инк. |
Способы лечения рака и профилактики лекарственной резистентности рака
|
EP2968537A1
(en)
|
2013-03-15 |
2016-01-20 |
Genentech, Inc. |
Methods of treating cancer and preventing cancer drug resistance
|
SI2970422T1
(en)
|
2013-03-15 |
2018-07-31 |
F. Hoffmann-La Roche Ag |
IL-22 polypeptides and IL-22-Fc fusion proteins and procedures for use
|
SG11201507333XA
(en)
|
2013-03-15 |
2015-10-29 |
Genentech Inc |
Biomarkers and methods of treating pd-1 and pd-l1 related conditions
|
TW202100181A
(zh)
|
2013-07-16 |
2021-01-01 |
美商建南德克公司 |
利用pd-1軸結合拮抗劑及tigit抑制劑治療癌症之方法
|
CN105899535A
(zh)
|
2013-12-17 |
2016-08-24 |
豪夫迈·罗氏有限公司 |
用pd-1轴结合拮抗剂和抗cd20抗体治疗癌症的方法
|
WO2015116902A1
(en)
|
2014-01-31 |
2015-08-06 |
Genentech, Inc. |
G-protein coupled receptors in hedgehog signaling
|
US8961992B1
(en)
|
2014-04-02 |
2015-02-24 |
Tunitas Therapeutics, Inc. |
Epsigam fusion protein
|
RU2713327C2
(ru)
|
2014-05-05 |
2020-02-04 |
Регенерон Фармасьютикалз, Инк. |
Гуманизированные животные по с5 и с3
|
JP2017524371A
(ja)
|
2014-05-23 |
2017-08-31 |
ジェネンテック, インコーポレイテッド |
Mitバイオマーカーとその使用方法
|
EP3154338B1
(en)
|
2014-06-10 |
2020-01-29 |
Biomatrica, INC. |
Stabilization of thrombocytes at ambient temperatures
|
US20230190750A1
(en)
|
2014-06-13 |
2023-06-22 |
Genentech, Inc. |
Methods of treating and preventing cancer drug resistance
|
JP6673896B2
(ja)
|
2014-07-15 |
2020-03-25 |
ジェネンテック, インコーポレイテッド |
Pd−1軸結合アンタゴニスト及びmek阻害剤を使用した癌を処置するための組成物
|
WO2016037157A2
(en)
|
2014-09-05 |
2016-03-10 |
The Johns Hopkins University |
Targeting capn9/capns2 activity as a therapeutic strategy for the treatment of myofibroblast differentiation and associated pathologies
|
RU2753902C2
(ru)
|
2014-11-20 |
2021-08-24 |
Ф.Хоффманн-Ля Рош Аг |
Комбинированная терапия на основе активирующих т-клетки биспецифических антигенсвязывающих молекул против cd3 и фолатного рецептора 1 (folr1) и антагонистов, связывающихся с осью pd-1
|
JP2017537929A
(ja)
|
2014-12-05 |
2017-12-21 |
ジェネンテック, インコーポレイテッド |
Pd−1軸アンタゴニスト及びhpk1アンタゴニストを用いたがん治療のための方法及び組成物
|
EP3237906B8
(en)
|
2014-12-23 |
2020-10-28 |
Bluelight Therapeutics, Inc. |
Attachment of proteins to interfaces for use in nonlinear optical detection
|
US10376535B2
(en)
|
2015-03-26 |
2019-08-13 |
University Of Rochester |
Therapy for malignant disease
|
EP4209228A1
(en)
|
2015-05-22 |
2023-07-12 |
Translational Drug Development, LLC |
Benzamide and active compound compositions and methods of use
|
WO2016205681A1
(en)
|
2015-06-19 |
2016-12-22 |
University Of Rochester |
Septin proteins as novel biomarkers for detection and treatment of müllerian cancers
|
CA3000386A1
(en)
|
2015-09-30 |
2017-04-06 |
Merck Patent Gmbh |
Combination of a pd-1 axis binding antagonist and an alk inhibitor for treating alk-negative cancer
|
EP3371211A4
(en)
|
2015-11-04 |
2019-08-21 |
Icahn School of Medicine at Mount Sinai |
METHOD FOR THE TREATMENT OF TUMORS AND CANCER AND IDENTIFICATION OF CANDIDATE PATIENTS FOR SUCH TREATMENT
|
KR20230145258A
(ko)
|
2015-12-08 |
2023-10-17 |
바이오매트리카 인코포레이티드 |
적혈구 침강 속도의 감소
|
WO2017112954A1
(en)
|
2015-12-23 |
2017-06-29 |
Moonshot Pharma Llc |
Methods for inducing an immune response by promoting premature termination codon read-through
|
US10329321B2
(en)
|
2016-02-09 |
2019-06-25 |
Alexander Krantz |
Site-selective functionalization of proteins using traceless affinity labels
|
US11246868B2
(en)
|
2016-04-26 |
2022-02-15 |
Icahn School Of Medicine At Mount Sinai |
Treatment of hippo pathway mutant tumors and methods of identifying subjects as candidates for treatment
|
AU2017292646A1
(en)
|
2016-07-05 |
2019-02-07 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
CN110023304A
(zh)
|
2016-09-28 |
2019-07-16 |
布莱德治疗公司 |
钙蛋白酶调节剂及其治疗用途
|
CN110234319B
(zh)
|
2016-11-23 |
2022-09-27 |
转化药物开发有限责任公司 |
苯甲酰胺和活性化合物的组合物及其使用方法
|
WO2018152496A1
(en)
|
2017-02-17 |
2018-08-23 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Compositions and methods for the diagnosis and treatment of zika virus infection
|
US10765762B2
(en)
|
2017-02-27 |
2020-09-08 |
Regeneron Pharmaceuticals, Inc. |
Humanized model of kidney and liver disorders
|
CN106916205B
(zh)
*
|
2017-03-31 |
2020-10-13 |
重庆理工大学 |
抗菌六肽及其衍生物和应用
|
CA3059615A1
(en)
|
2017-04-21 |
2018-10-25 |
Genentech, Inc. |
Use of klk5 antagonists for treatment of a disease
|
EP3615569A1
(en)
|
2017-04-25 |
2020-03-04 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Antibodies and methods for the diagnosis and treatment of epstein barr virus infection
|
JP2020525434A
(ja)
|
2017-06-22 |
2020-08-27 |
ムーンショット ファーマ エルエルシー |
アンレキサノクス及び免疫調節剤を含む組成物で癌を治療する方法
|
CN111094334A
(zh)
|
2017-07-19 |
2020-05-01 |
美国卫生与公众服务部 |
用于诊断和治疗乙肝病毒感染的抗体和方法
|
US11400165B2
(en)
|
2017-11-04 |
2022-08-02 |
Advanced Proteome Therapeutics Inc. |
Composition and method for modifying polypeptides
|
TW201929907A
(zh)
|
2017-12-22 |
2019-08-01 |
美商建南德克公司 |
Pilra結合劑用於治療疾病之用途
|
CN110102263A
(zh)
*
|
2019-04-10 |
2019-08-09 |
中国药科大学 |
巯基乙胺功能化磁性氧化石墨烯吸附剂及其制备方法和应用
|
WO2020239558A1
(en)
|
2019-05-24 |
2020-12-03 |
Pfizer Inc. |
Combination therapies using cdk inhibitors
|
EP4055029A4
(en)
|
2019-11-08 |
2023-11-22 |
University of Pittsburgh - of the Commonwealth System of Higher Education |
COMPOSITIONS COMPRISING ANTIMICROBIAL PEPTIDES
|
KR20230091871A
(ko)
|
2020-10-20 |
2023-06-23 |
에프. 호프만-라 로슈 아게 |
Pd-1 축 결합 길항제 및 lrrk2 억제제의 병용 요법
|
WO2022118197A1
(en)
|
2020-12-02 |
2022-06-09 |
Pfizer Inc. |
Time to resolution of axitinib-related adverse events
|
CA3216220A1
(en)
|
2021-06-09 |
2022-12-15 |
F. Hoffmann-La Roche Ag |
Combination of a particular braf inhibitor (paradox breaker) and a pd-1 axis binding antagonist for use in the treatment of cancer
|
WO2023057882A1
(en)
|
2021-10-05 |
2023-04-13 |
Pfizer Inc. |
Combinations of azalactam compounds with a pd-1 axis binding antagonist for the treatment of cancer
|